TI
WHWK

Truepoint Inc’s Whitehawk Therapeutics WHWK Stock Holding History

Truepoint Inc’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,219
Closed – – 174
2022
Q1 		$0 Hold
10,219
– – ﹤0.01% 148
2021
Q4 		$0 Hold
10,219
– – ﹤0.01% 141
2021
Q3 		$22K Buy
10,219
+9,538
+1,401% +$291K ﹤0.01% 130
2021
Q2 		$17K Hold
681
– – ﹤0.01% 121
2021
Q1 		$13K Hold
681
– – ﹤0.01% 114
2020
Q4 		$10K Buy
+681
New +$14.6K ﹤0.01% 110
2020
Q1 		– Sell
-681
Closed -$6K – 119
2019
Q4 		$6K Hold
681
– – ﹤0.01% 117
2019
Q3 		$7K Hold
681
– – ﹤0.01% 110
2019
Q2 		$9K Hold
681
– – ﹤0.01% 121
2019
Q1 		$9K Hold
681
– – ﹤0.01% 111
2018
Q4 		$17K Hold
681
– – ﹤0.01% 101
2018
Q3 		$32K Hold
681
– – ﹤0.01% 103
2018
Q2 		$42K Buy
+681
New +$41.2K ﹤0.01% 106

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Truepoint Inc's WHWK Position: Q2 2022 in Review

Truepoint Inc sold out of Whitehawk Therapeutics (WHWK) in Q2 2022, closing a stake of 10,219 shares.

Truepoint Inc first reported a position in WHWK in Q2 2018 and held it in 13 quarters. The position peaked at $42K in Q2 2018. 68 funds tracked by Wall St. Rank hold WHWK as of Q2 2022.

  • Truepoint Inc reported no remaining Whitehawk Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Truepoint Inc sold 10,219 Whitehawk Therapeutics shares in Q2 2022.
  • Truepoint Inc first reported a position in Whitehawk Therapeutics in Q2 2018 and held it in 13 quarters.
  • Truepoint Inc's Whitehawk Therapeutics position peaked at $42K in Q2 2018.
  • 68 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2022.

Based on Truepoint Inc's 13F filing for Q2 2022, filed 8 Aug 2022.